Pricing
Login
Home
Charts
Search
Watchlist
Products

Anthem Biosciences Ltd

ANTHEM
₹951.05+1.52%20 Nov 2026
Reports
Pharma CRAMS

Anthem Biosciences Ltd

ANTHEM
₹951.05
+1.52%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹53,589Cr
Close
Close Price
₹951.05
Industry
Industry
Pharma CRAMS
PE
Price To Earnings
87.17
PS
Price To Sales
26.19
Revenue
Revenue
₹2,046Cr
Rev Gr TTM
Revenue Growth TTM
-1.20%
PAT Gr TTM
PAT Growth TTM
18.95%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
339525498483540550423611418594
Growth YoY
Revenue Growth YoY%
59.54.8-15.026.4-22.68.0
Expenses
ExpensesCr
218330338288349332266344268323
Operating Profit
Operating ProfitCr
121195160195192218157267151271
OPM
OPM%
35.737.232.040.435.539.637.143.736.045.7
Other Income
Other IncomeCr
1928241423488522559
Interest Expense
Interest ExpenseCr
4431230213
Depreciation
DepreciationCr
19202030263435403031
PBT
PBTCr
118200161178186230130278145296
Tax
TaxCr
36383796505638882585
PAT
PATCr
821621248313617393190120211
Growth YoY
PAT Growth YoY%
64.87.1-25.3129.7-11.721.9
NPM
NPM%
24.330.925.017.125.131.521.931.128.735.6
EPS
EPS₹
1.52.92.21.52.43.11.63.42.13.8
QuarterJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
339525498483540550423611418594
Growth YoY
Revenue Growth YoY%
59.54.8-15.026.4-22.68.0
Expenses
ExpensesCr
218330338288349332266344268323
Operating Profit
Operating ProfitCr
121195160195192218157267151271
OPM
OPM%
35.737.232.040.435.539.637.143.736.045.7
Other Income
Other IncomeCr
1928241423488522559
Interest Expense
Interest ExpenseCr
4431230213
Depreciation
DepreciationCr
19202030263435403031
PBT
PBTCr
118200161178186230130278145296
Tax
TaxCr
36383796505638882585
PAT
PATCr
821621248313617393190120211
Growth YoY
PAT Growth YoY%
64.87.1-25.3129.7-11.721.9
NPM
NPM%
24.330.925.017.125.131.521.931.128.735.6
EPS
EPS₹
1.52.92.21.52.43.11.63.42.13.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6331,1031,2311,0571,4191,8452,1242,046
Growth
Revenue Growth%
74.411.6-14.234.330.015.2-1.2
Expenses
ExpensesCr
4516966666289141,1741,2911,200
Operating Profit
Operating ProfitCr
182408565429505671834846
OPM
OPM%
28.837.045.940.635.636.439.341.4
Other Income
Other IncomeCr
2137491396486131144
Interest Expense
Interest ExpenseCr
2017107101076
Depreciation
DepreciationCr
626258648289134135
PBT
PBTCr
121366546497477657824849
Tax
TaxCr
2894141112110206232235
PAT
PATCr
93271406385367451592614
Growth
PAT Growth%
192.749.5-5.0-4.622.931.118.9
NPM
NPM%
14.724.632.936.425.924.527.930.0
EPS
EPS₹
108.0323.4467.66.86.58.110.610.9
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6331,1031,2311,0571,4191,8452,1242,046
Growth
Revenue Growth%
74.411.6-14.234.330.015.2-1.2
Expenses
ExpensesCr
4516966666289141,1741,2911,200
Operating Profit
Operating ProfitCr
182408565429505671834846
OPM
OPM%
28.837.045.940.635.636.439.341.4
Other Income
Other IncomeCr
2137491396486131144
Interest Expense
Interest ExpenseCr
2017107101076
Depreciation
DepreciationCr
626258648289134135
PBT
PBTCr
121366546497477657824849
Tax
TaxCr
2894141112110206232235
PAT
PATCr
93271406385367451592614
Growth
PAT Growth%
192.749.5-5.0-4.622.931.118.9
NPM
NPM%
14.724.632.936.425.924.527.930.0
EPS
EPS₹
108.0323.4467.66.86.58.110.610.9
Sales CAGR
1 Year15%
3 Years26%
5 Years14%
TTM-1%
EBITDA CAGR
1 Year24%
3 Years25%
5 Years15%
TTM11%
PAT CAGR
1 Year31%
3 Years15%
5 Years17%
TTM19%
Avg. ROCE
1 Year27%
3 Years25%
5 Years29%
TTM26%
CFO / EBITDA
1 Year101%
3 Years62%
5 Years63%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
889114112112112113
Reserves
ReservesCr
4136931,3461,6271,8132,2982,9303,168
Current Liabilities
Current LiabilitiesCr
247285223164339326326340
Non Current Liabilities
Non Current LiabilitiesCr
1184741110135716165
Total Liabilities
Total LiabilitiesCr
7871,0341,6192,0142,3982,8083,4293,686
Current Assets
Current AssetsCr
4036161,0981,3231,4821,4881,8031,881
Non Current Assets
Non Current AssetsCr
3844185216919171,3191,6261,805
Total Assets
Total AssetsCr
7871,0341,6192,0142,3982,8083,4293,686
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
889114112112112113
Reserves
ReservesCr
4136931,3461,6271,8132,2982,9303,168
Current Liabilities
Current LiabilitiesCr
247285223164339326326340
Non Current Liabilities
Non Current LiabilitiesCr
1184741110135716165
Total Liabilities
Total LiabilitiesCr
7871,0341,6192,0142,3982,8083,4293,686
Current Assets
Current AssetsCr
4036161,0981,3231,4821,4881,8031,881
Non Current Assets
Non Current AssetsCr
3844185216919171,3191,6261,805
Total Assets
Total AssetsCr
7871,0341,6192,0142,3982,8083,4293,686

Cash Flow

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
166278333306140271844
Investing Cash Flow
Investing Cash FlowCr
-109-196-205-376-221-147-702
Financing Cash Flow
Financing Cash FlowCr
-48-6318164-77-136-40
Net Cash Flow
Net Cash FlowCr
918308-6-158-12103
Free Cash Flow
Free Cash FlowCr
1241633111273112637
CFO To PAT
CFO To PAT%
178.6102.382.179.438.260.0142.7
CFO To EBITDA
CFO To EBITDA%
91.068.158.971.327.840.3101.3
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
166278333306140271844
Investing Cash Flow
Investing Cash FlowCr
-109-196-205-376-221-147-702
Financing Cash Flow
Financing Cash FlowCr
-48-6318164-77-136-40
Net Cash Flow
Net Cash FlowCr
918308-6-158-12103
Free Cash Flow
Free Cash FlowCr
1241633111273112637
CFO To PAT
CFO To PAT%
178.6102.382.179.438.260.0142.7
CFO To EBITDA
CFO To EBITDA%
91.068.158.971.327.840.3101.3

Ratios

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
36,86553,589
Price To Earnings
Price To Earnings
62.387.2
Price To Sales
Price To Sales
17.426.2
Price To Book
Price To Book
12.116.3
EV To EBITDA
EV To EBITDA
44.063.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
54.054.361.962.253.454.856.956.9
OPM
OPM%
28.837.045.940.635.636.439.341.4
NPM
NPM%
14.724.632.936.425.924.527.930.0
ROCE
ROCE%
26.047.740.027.022.526.426.825.8
ROE
ROE%
22.038.729.922.119.118.719.418.7
ROA
ROA%
11.826.225.119.115.316.117.316.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
36,86553,589
Price To Earnings
Price To Earnings
62.387.2
Price To Sales
Price To Sales
17.426.2
Price To Book
Price To Book
12.116.3
EV To EBITDA
EV To EBITDA
44.063.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
54.054.361.962.253.454.856.956.9
OPM
OPM%
28.837.045.940.635.636.439.341.4
NPM
NPM%
14.724.632.936.425.924.527.930.0
ROCE
ROCE%
26.047.740.027.022.526.426.825.8
ROE
ROE%
22.038.729.922.119.118.719.418.7
ROA
ROA%
11.826.225.119.115.316.117.316.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr2,96,8071,23,98053,58938,27931,85931,38526,483
Close PriceClose₹11,180.502,294.60951.051,800.70239.303,833.5020,642.00
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE88.2292.4587.17101.2271.4758.52
Price To SalesPS24.3515.8526.1916.143.2619.7111.48
RevenueRevenueCr12,1917,8232,0462,3719,7791,5932,307
Revenue Growth TTMRev Gr TTM%21.6%23.0%-1.2%15.5%9.4%45.2%50.5%
PAT Growth TTMPAT Gr TTM%35.3%96.3%18.9%31.4%-782.0%95.8%88.4%
Market CapitalizationMkt CapCr2,96,8071,23,98053,58938,27931,85931,38526,483
Close PriceClose₹11,180.502,294.60951.051,800.70239.303,833.5020,642.00
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE88.2292.4587.17101.2271.4758.52
Price To SalesPS24.3515.8526.1916.143.2619.7111.48
RevenueRevenueCr12,1917,8232,0462,3719,7791,5932,307
Revenue Growth TTMRev Gr TTM%21.6%23.0%-1.2%15.5%9.4%45.2%50.5%
PAT Growth TTMPAT Gr TTM%35.3%96.3%18.9%31.4%-782.0%95.8%88.4%